statistiche ricercatore

MANCINI, NICASIO

Distribuzione geografica

Continente	#
NA - Nord America	7.355
EU - Europa	4.160
AS - Asia	4.108
Continente sconosciuto - Info sul continente non disponibili	502
SA - Sud America	452
AF - Africa	95
OC - Oceania	14
Totale	16.686

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7.100
IT - Italia	2.480
SG - Singapore	1.779
CN - Cina	857
HK - Hong Kong	604
BR - Brasile	380
VN - Vietnam	375
GB - Regno Unito	289
FR - Francia	255
DE - Germania	213
RU - Federazione Russa	179
FI - Finlandia	165
IE - Irlanda	156
CA - Canada	133
IN - India	109
SE - Svezia	103
BD - Bangladesh	95
UA - Ucraina	91
MX - Messico	80
TR - Turchia	79
JP - Giappone	50
PL - Polonia	40
AT - Austria	39
NL - Olanda	39
ES - Italia	31
IQ - Iraq	28
ZA - Sudafrica	27
AR - Argentina	25
NG - Nigeria	23
SA - Arabia Saudita	21
BE - Belgio	19
LT - Lituania	18
AE - Emirati Arabi Uniti	13
PK - Pakistan	12
AU - Australia	11
CH - Svizzera	11
KE - Kenya	11
CO - Colombia	10
MY - Malesia	10
VE - Venezuela	10
ID - Indonesia	9
MA - Marocco	9
UZ - Uzbekistan	9
CR - Costa Rica	8
EC - Ecuador	8
JO - Giordania	8
AZ - Azerbaigian	6
CL - Cile	6
PE - Perù	6
PH - Filippine	6
TN - Tunisia	6
EG - Egitto	5
IL - Israele	5
JM - Giamaica	5
MD - Moldavia	5
TT - Trinidad e Tobago	5
BB - Barbados	4
ET - Etiopia	4
GR - Grecia	4
GT - Guatemala	4
KR - Corea	4
LB - Libano	4
BG - Bulgaria	3
BH - Bahrain	3
CI - Costa d'Avorio	3
HN - Honduras	3
NI - Nicaragua	3
NO - Norvegia	3
PR - Porto Rico	3
UY - Uruguay	3
BY - Bielorussia	2
CZ - Repubblica Ceca	2
DK - Danimarca	2
EE - Estonia	2
EU - Europa	2
GE - Georgia	2
IR - Iran	2
KH - Cambogia	2
KZ - Kazakistan	2
NP - Nepal	2
PA - Panama	2
PY - Paraguay	2
QA - Qatar	2
RS - Serbia	2
RW - Ruanda	2
SI - Slovenia	2
SV - El Salvador	2
TH - Thailandia	2
VC - Saint Vincent e Grenadine	2
AF - Afghanistan, Repubblica islamica di	1
AL - Albania	1
AO - Angola	1
BN - Brunei Darussalam	1
BO - Bolivia	1
BZ - Belize	1
CG - Congo	1
CY - Cipro	1
GA - Gabon	1
GN - Guinea	1
GY - Guiana	1
Totale	16.173

Salva come PNG Salva come JPEG

Città	#
Milan	1.436
San Jose	1.175
Singapore	944
Ashburn	727
Council Bluffs	626
Hong Kong	593
Dallas	477
Chicago	446
Beijing	302
The Dalles	243
Boardman	218
Lauterbourg	179
London	176
Los Angeles	175
Dublin	151
Fairfield	141
Rome	141
Santa Clara	112
Ho Chi Minh City	111
Helsinki	107
Varese	107
New York	104
Chandler	94
Hanoi	86
Seattle	81
Jacksonville	74
Munich	71
Houston	61
Como	60
Salt Lake City	57
Woodbridge	55
Frankfurt am Main	52
Wilmington	52
Mexico City	51
Brooklyn	49
Ogden	49
Chennai	45
Washington	45
Tokyo	43
Toronto	43
Atlanta	42
Ann Arbor	41
Orem	38
Nyköping	35
Warsaw	35
Montreal	33
São Paulo	33
Cambridge	32
Tampa	32
Guangzhou	31
Princeton	31
Denver	30
San Francisco	29
Vienna	29
Izmir	26
Magnago	26
Nuremberg	26
Elk Grove Village	24
Lancaster	24
Phoenix	24
Abuja	23
Boston	23
Dearborn	23
Shanghai	23
Da Nang	22
Johannesburg	21
San Diego	20
Amsterdam	19
Buffalo	19
Shenzhen	18
Brussels	17
Haiphong	16
West Jordan	16
Dhaka	15
Rio de Janeiro	15
Vancouver	15
Stockholm	14
Ankara	13
Belo Horizonte	13
Lappeenranta	13
Memphis	13
Poplar	13
Assago	12
Manchester	12
Mumbai	12
New Delhi	12
Turku	12
Verona	12
Charlotte	11
Nairobi	11
Pune	11
Sterling	11
Hangzhou	10
Miami	10
Pittsburgh	10
Baghdad	9
Detroit	9
Dulles	9
Düsseldorf	9
Jeddah	9
Totale	10.955

Salva come PNG Salva come JPEG

Nome	#
A diet enriched in omega-3 PUFA and inulin prevents type 1 diabetes by restoring gut barrier integrity and immune homeostasis in NOD mice	541
Characterization of a lineage C.36 SARS-CoV-2 isolate with reduced susceptibility to neutralization circulating in Lombardy, Italy	480
Antigen-driven evolution of B lymphocytes in coronary atherosclerotic plaques.	196
Coronaviridae and SARS-associated coronavirus strain HSR1.	195
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	192
Anti-HIV-1 response elicited in rabbits by anti-idiotype monoclonal antibodies mimicking the CD4-binding site.	183
Global spread of Streptococcus pyogenes A genomics-supported narrative review	182
Cross-reactive pseudovirus-neutralizing anti-envelope antibodies coexist with antibodies devoid of such activity in persistent hepatitis C virus infection.	182
Monoclonal antibodies isolated from human B cells neutralize a broad range of H1 subtype influenza A viruses including swine-origin Influenza virus (S-OIV).	172
Multicenter Cross-sectional Study on the Epidemiology of Human Metapneumovirus in Italy, 2022–2024, With a Focus on Adults Over 50 Years of Age	170
Cloning and molecular characterization of a human recombinant IgG Fab binding to the Tat protein of human immunodeficiency virus type 1 (HIV-1) derived from the repertoire of a seronegative patient.	167
Quantitation of Bacillus clausii in biological samples by real-time polymerase chain reaction.	162
Circulating SARS-CoV-2 variants in Italy, October 2020-March 2021	161
A modified Frosch approach for posterior tibial plateau fractures: technical note and case series	147
SARS-CoV-2 detection in primary thyroid sarcoma: coincidence or interaction?	143
A phage display vector optimized for the generation of human antibody combinatorial libraries and the molecular cloning of monoclonal antibody fragments.	142
A spatial multi-scale fluorescence microscopy toolbox discloses entry checkpoints of SARS-CoV-2 variants in Vero E6 cells	140
A biologically-validated HCV E1E2 heterodimer structural model	125
ACOD1 deficiency offers protection in a mouse model of diet-induced obesity by maintaining a healthy gut microbiota	121
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies.	120
In Vitro Antimicrobial Activity of the Siderophore Cephalosporin Cefiderocol against Acinetobacter baumannii Strains Recovered from Clinical Samples	118
A Human Monoclonal Antibody with Neutralizing Activity against Highly Divergent Influenza Subtypes	118
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19	115
Analysis of the faecal microbiome during analytical treatment interruption in people with chronic HIV infection and long-lasting virological suppression (APACHE study)	115
Type III interferons disrupt the lung epithelial barrier upon viral recognition	113
Phage display for the production of human monoclonal antibodies against human pathogens.	113
Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	111
Humoral immune response against hepatitis C virus.	111
Nanopore ReCappable sequencing maps SARS-CoV-2 5' capping sites and provides new insights into the structure of sgRNAs	110
Mechanisms of Hepatitis C Virus Escape from Vaccine-Relevant Neutralizing Antibodies	107
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients	107
Dose-Dependent Impairment of the Immune Response to the Moderna-1273 mRNA Vaccine by Mycophenolate Mofetil in Patients with Rheumatic and Autoimmune Liver Diseases	106
Molecular cloning of the first human monoclonal antibodies neutralizing with high potency swine-origin influenza A pandemic virus (S-OIV).	106
Broadly neutralizing anti-influenza human monoclonal antibodies and their possible role in predictive medicine	105
Clinical characterization and whole genome sequence-based typing of two cases of endophthalmitis due to Listeria monocytogenes	104
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses	104
A case of psoriatic arthritis triggered by SARS-CoV-2 infection	102
The IN SIGNO project: Identification of novel molecules supporting the impact of β-lactams against clinically-relevant Gram-negative multidrug resistant organisms	101
Chimeric antigen receptor (CAR)-engineered T cells redirected against hepatitis C virus (HCV) E2 glycoprotein	101
Characterization of epitopes recognized by monoclonal antibodies: experimental approaches supported by freely accessible bioinformatic tools	100
Proper Selection of In Vitro Cell Model Affects the Characterization of the Neutralizing Antibody Response against SARS-CoV-2	100
Adoptive T-cell therapy in the treatment of viral and opportunistic fungal infections	100
Molecular diagnosis of sepsis in neutropenic patients with haematological malignancies	99
Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening	99
Antibody Titer Kinetics and SARS-CoV-2 Infections Six Months after Administration with the BNT162b2 Vaccine	97
IFCC interim guidelines on rapid point-of-care antigen testing for SARS-CoV-2 detection in asymptomatic and symptomatic individuals	96
Maturation signatures of conventional dendritic cell subtypes in COVID‐19 suggest direct viral sensing	96
Acute respiratory distress in a neutropenic febrile patient after hematopoietic cell transplantation	94
Genomic Epidemiology of the Main SARS-CoV-2 Variants Circulating in Italy During the Omicron Era	94
Novel therapeutic investigational strategies to treat severe and disseminated HSV infections suggested by a deeper understanding of in vitro virus entry processes	93
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models	93
Possible future monoclonal antibody (mAb)-based therapy against arbovirus infections	93
Autoimmune hepatitis and occult HCV infection: A prospective single-centre clinical study	93
Sex-specific Alterations in the Urinary and Tissue Microbiome in Therapy-naïve Urothelial Bladder Cancer Patients	91
The efficacy of ultraviolet light-emitting technology against coronaviruses: a systematic review	90
Combined Use of Phenotypic Screening and of a Novel Commercial Assay (REALQUALITY Carba-Screen) for the Rapid Molecular Detection of Carbapenemases: A Single-Center Experience	90
Answer to photo quiz: Streptococcus pneumoniae	89
An outbreak caused by multidrug-resistant OXA-58-positive Acinetobacter baumannii in an intensive care unit in Italy	89
Phage display-based strategies for cloning and optimization of monoclonal antibodies directed against human pathogens	89
Levofloxacin prophylaxis vs no prophylaxis in neutropenic patients within an endemic country for carbapenem-resistant GNB	88
A human stem cell-derived neurosensory–epithelial circuitry on a chip to model herpes simplex virus reactivation	88
Differential composition of vaginal microbiome, but not of seminal microbiome, is associated with successful intrauterine insemination in couples with idiopathic infertility: A prospective observational study	87
Epidemiological impact of human adenovirus as causative agent of respiratory infections: An Italian multicentre retrospective study, 2022–2023	87
The interferon landscape along the respiratory tract impacts the severity of COVID-19	87
Global and local envelope protein dynamics of hepatitis C virus determine broad antibody sensitivity	87
Neutralization Interfering Antibodies: a "Novel" Mechanism of Humoral Immune Mutiny and Viral Evasion?	86
A closer look at prion strains: characterization and important implications	85
Unconventional CD147-dependent platelet activation elicited by SARS-CoV-2 in COVID-19	85
JN.1 variants circulating in Italy from October 2023 to April 2024: genetic diversity and immune recognition	84
JC polyomavirus (JCV) and monoclonal antibodies: friends or potential foes?	84
Molecular characterization of the human neutralizing response against hepatitis C virus and its role in the prediction of the infection outcome	84
Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference	84
Identification of a novel mutation involved in colistin resistance in Klebsiella pneumoniae through Next-Generation Sequencing (NGS) based approaches	84
Detection of low-level HCV variants in DAA treated patients: comparison amongst three different NGS data analysis protocols	83
Cell-to-cell spread-blocking activity is extremely limited in the sera of HSV-1 and HSV-2 infected subjects	83
Epidemiological characteristics of non-polio enteroviruses in respiratory infections: An Italian multicentre retrospective study, 2022–2023	82
Combined prophylactic and therapeutic use maximizes hydroxychloroquine anti-SARS-CoV-2 effects in vitro	82
Microbiome studies in the medical sciences and the need for closer multidisciplinary interplay	79
IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19	79
Geographical and temporal distribution of SARS-CoV-2 clades in the WHO European Region, January to June 2020	79
Heterosubtypic protection conferred by the human monoclonal antibody PN-SIA28 against influenza A virus lethal infections in mice	78
Fast inactivation of SARS-CoV-2 by UV-C and ozone exposure on different materials	78
Molecular characterization of emerging Echovirus 11 (E11) shed light on the recombinant origin of a variant associated with severe hepatitis in neonates	78
Lower nasopharyngeal viral load during the latest phase of COVID-19 pandemic in a Northern Italy University Hospital	78
Molecular signatures of hepatitis C virus (HCV)-induced type II mixed cryoglobulinemia (MCII)	78
Viral respiratory pathogens and lung Injury	77
IFCC interim guidelines on molecular testing of SARS-CoV-2 infection	76
Microbiome markers are early predictors of acute GvHD in allogeneic hematopoietic stem cell transplant recipients	76
Operational considerations and challenges of biochemistry laboratories during the COVID-19 outbreak: An IFCC global survey	75
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients	75
Chimeric antigen receptor (CAR)-redirected T cells: is there a place for them in infectious diseases?	73
SARS-CoV-2 infection despite high levels of vaccine-induced anti-Receptor-Binding-Domain antibodies: a study on 1110 health-care professionals from a northern Italian university hospital	73
Torquetenovirus Viremia Quantification Using Real-Time PCR Developed on a Fully Automated, Random-Access Platform	73
Risks of "blind" automated identification systems in medical microbiology	72
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia	72
Molecular, serological, and biochemical diagnosis and monitoring of COVID-19: IFCC taskforce evaluation of the latest evidence	72
Hepatitis C virus (HCV) infection may elicit neutralizing antibodies targeting epitopes conserved in all viral genotypes	72
Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects	71
A family cluster of Streptococcus pyogenes associated with a fatal early-onset neonatal sepsis	71
Very high SARS-CoV-2 load at the emergency department presentation strongly predicts the risk of admission to the intensive care unit and death	71
Totale	11.129

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	85.079
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	85.079

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	208	0	43	20	17	4	0	35	21	16	21	11	20
2022/2023	704	19	7	13	34	34	52	0	39	267	129	35	75
2023/2024	2.699	371	395	336	500	572	254	23	55	79	66	12	36
2024/2025	3.254	24	58	629	141	102	159	134	134	353	184	465	871
2025/2026	8.073	594	409	616	987	541	292	1.857	436	961	550	455	375
2026/2027	1.041	689	352	0	0	0	0	0	0	0	0	0	0
Totale													16.686